Physician profile
Robert Paul Flick
NPI 1265481972
$3,855.02
in general payments reported to CMS, 2019-2025
44 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $373 · 2021: $626 · 2022: $1,200 · 2023: $644 · 2024: $398 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $739.86 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Channel Medsystems, INC. | $388.71 | 2022-2024 | |
| Abbott Laboratories | $315.47 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $310.32 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $305.73 | 2019-2025 | Wegovy |
| Abbvie INC. | $196.98 | 2019-2025 | |
| Amarin Pharma, INC. | $196.01 | 2019-2022 | |
| Exact Sciences Corporation | $167.32 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $149.87 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $117.49 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.78 | 2019-2023 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.83 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $63.75 | 2022-2023 | Gvoke Hypopen |
| Pfizer INC. | $57.14 | 2021-2025 | |
| Axsome Therapeutics, INC. | $52.28 | 2023 | Auvelity |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Flick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.